Hypnosis, Virtual Reality and Their Combination in Bone Marrow Examination

Sponsor
Bnai Zion Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05982249
Collaborator
(none)
100
1
4
35.6
2.8

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the effects of hypnosis, virtual reality or their combination in patients undergoing a bone marrow procedure.

The main question it aims to answer is whether such interventions may relieve anxiety and other symptoms described by patients undergoing the procedure.

Before the bone marrow procedure and after being explained on the study and signing informed consent, the nurse will measure vital signs and participants will fill-out a 2-minutes' questionnaire and will be assigned to one of 4 groups:

  • Hearing a 7-minutes hypnotic script via earphones

  • Seeing and hearing virtual images and sounds via a virtual reality device during 7 minutes

  • Both heating a 7-minutes hypnotic script via earphones and seeing virtual images via a virtual reality device

  • None of these After these interventions or 10 minutes after assignation for patients not receiving intervention, patients will fill questionnaires again (about 5 minutes for filling the 2 questionnaires) and vital signs will be measured again. Then the bone marrow procedure will be performed. After the bone marrow procedure, the participants will fill-out another 2-minutes questionnaire and vital signs will be measured by the nurse.

Researchers will compare hypnotic script, virtual reality, their combination or none of them to see if they can affect anxiety and other complaints in patients undergoing a bone marrow procedure.

Condition or Disease Intervention/Treatment Phase
  • Device: Hypnosis
  • Device: Virtual reality (VR)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Open label randomized controlled trialOpen label randomized controlled trial
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effectiveness of Recorded Hypnosis, Virtual Reality or Their Combination in Patients Undergoing a Bone Marrow Examination at the Hematology Unit
Actual Study Start Date :
Jul 13, 2023
Anticipated Primary Completion Date :
Jul 1, 2026
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hypnosis (H)

Patients will be given earphones to hear a hypnotic script that was recorded by Dr. Zahi Arnon, a psychologist specializing in hypnosis after observing about ten bone marrow (BM) examinations at the hematology institute. The length of the recording is about 7 minutes.

Device: Hypnosis
Patients will be given earphones to hear a hypnotic script that was recorded by Dr. Zahi Arnon, a psychologist specializing in hypnosis after observing about ten BM examinations at the hematology institute. The length of the recording is about 7 minutes.

Experimental: Virtual reality (VR)

Patients will be connected to a VR device that will transmit to the patient's choice a 3D screen and soothing noise for about 7 minutes.

Device: Virtual reality (VR)
Patients will be connected to a VR device that will transmit to the patient's choice a 3D screen and soothing noise for about 7 minutes.

Experimental: Combined hypnosis and virtual reality (VRH)

Patients will hear the same 7-minutes hypnotic script by earphones and simultaneously be connected to the VR device that will show the 3D screen without soothing noise.

Device: Hypnosis
Patients will be given earphones to hear a hypnotic script that was recorded by Dr. Zahi Arnon, a psychologist specializing in hypnosis after observing about ten BM examinations at the hematology institute. The length of the recording is about 7 minutes.

Device: Virtual reality (VR)
Patients will be connected to a VR device that will transmit to the patient's choice a 3D screen and soothing noise for about 7 minutes.

No Intervention: Control (C)

Outcome Measures

Primary Outcome Measures

  1. Symptoms experienced by patients undergoing bone marrow procedure [Through study completion, an average of 1 hour]

    Measure Yourself Concerns and Wellbeing (MYCAW) questionnaire: requires participants to nominate one or two concerns and, using a seven-point scale from 0 (worse outcome) to 6 (best outcome), to score these concerns and their general feeling of wellbeing

Secondary Outcome Measures

  1. Absorption, dissociation, immersion and time perception [Through study completion, an average of 1 hour]

    Validated questionnaire on absorption, dissociation, immersion and time perception

  2. Sedation [Through study completion, an average of 1 hour]

    Type and dose of sedation used during procedure

  3. Use of analgesics [Through study completion, an average of 1 hour]

    Type and dose of analgesics

  4. Blood pressure [Through study completion, an average of 1 hour]

    Blood pressure

  5. Pulse [Through study completion, an average of 1 hour]

    Pulse

  6. Respiratory rate [Through study completion, an average of 1 hour]

    Respiratory rate

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age 18 or older

  2. Candidate for a BM examination at the hematology unit

  3. Ability to answer questionnaires in Hebrew, Arabic or Russian

  4. Informed consent form signing

Exclusion Criteria:
  1. Major hearing impairment

  2. Major visual impairment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bnai Zion Medical Center Haifa Israel 3339419

Sponsors and Collaborators

  • Bnai Zion Medical Center

Investigators

  • Principal Investigator: Ilana Levy Yurkovski, MD, Bnai Zion Medical Center

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Bnai Zion Medical Center
ClinicalTrials.gov Identifier:
NCT05982249
Other Study ID Numbers:
  • 0053-23-BNZ
First Posted:
Aug 8, 2023
Last Update Posted:
Aug 8, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bnai Zion Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2023